Transforming the Boundaries of PerformanceNanophase Technologies: Nanomaterials and Nanotechnology Leader
MarketsApplicationsProductsTechnolgiesCorporateInvestors RelationsEmploymentContact UsSearch





Investors Relations


SECOND QUARTER 2001 CONFERENCE CALL

Joseph Cross, President and CEO

  • Welcome to our second quarter 2001 conference call. The Nanophase attendees for this session are: Dan Bilicki, VP Sales and Marketing; Dr. Don Freed, VP Business Development; Dr. Gina Kritchevsky, VP Technology and Engineering; Dr. Richard Brotzman, VP R&D; Jess Jankowski, CFO and Corporate Controller; and Bob Haines, VP of Operations.


  • To begin, Jess Jankowski will review the financial results for the second quarter and the first 6 months.

Jess Jankowski, CFO and Controller

  • Good morning and thank you for attending.


  • For the second quarter of 2001, our revenues were approximately $1,049,000 versus $1,105,000 for the same quarter in 2000. The majority of our revenues continue to come from products.


  • We had approximately $43,000 in gross margin for the second quarter of this year. This was achieved mainly through many of the Company's manufacturing cost-saving measures being fully recognized in second quarter production. We also incurred a charge to inventory of approximately $110,000 due to costs of production being lowered to the extent where we felt an adjustment to reflect lower current costs was prudent. We feel that gross margins should remain positive through the balance of the year. The extent to which they remain positive, as a percentage of revenue, will be dependent upon revenue mix, revenue volume, and the Company's ability to continue to cut costs. Continued savings relative to manufacturing costs should boost the gross margin, relative to this quarter, in the second half of the year. On the bottom line, we lost 9 cents per share for the second quarter of this year versus 9 cents per share for the second quarter of 2000. We increased our allowance for doubtful accounts, relating to a collection issue, by approximately $120,000, which contributed approximately one cent to our loss for the quarter.

  • For the six months ended June 30, 2001, revenues were approximately $2.2million versus $1.7million for the same period in 2000. With respect to earnings per share, Nanophase lost 18 cents per share for the six months ended June 30, 2001 versus 20 cents per share for the same period in 2000.

  • I would now like to spend a little time walking you through the major categories on the June 30, 2001 balance sheet:

  • All numbers are approximate….

    • At June 30th, Nanophase had $12.8million in cash and investments.

    • Accounts Receivable amounted to $542,000. Receivables, in relation to sales, have come down dramatically. Our largest customer, who was formerly at 60-day terms, is now at 30-day terms and up to date on payments.

    • Inventory has gone up by $625,000 between the end of last quarter and June 30th. Much of this build-up was anticipated and controlled by management. We are now at the peak of the inventory plan announced earlier this year. The majority of 6/30 inventory relates to product or materials for the Company's largest customer.

  • The only material in inventory that had been unanticipated is $350,000 worth of both raw and finished goods built in order to satisfy anticipated business from a catalytic fuel additive customer that did not materialize in the second quarter, as originally expected. This business may materialize later in the year. In the third quarter, we will have an additional $300,000 of raw materials coming in to support this same business. The reason that we have accumulated as much of this material as we have is that the lead-time, from start to finish, is three to four months. None of this material will be wasted, but our schedule to produce and ship the balance of it will be moved out into 2002. We intend to reduce current inventory levels by approximately 20% by the end of the year. We continue to manage this situation closely.

  • Changing to another key area of focus:

    • Capital expenditures have amounted to $3.8 million dollars in the first six months of this year. We anticipate spending an additional $3.5million in the balance of the year.

  • Most of our spending is earmarked for three main categories:
  • + The pilot manufacturing facility in Romeoville

    + The powder coating area in Romeoville

    (Includes upgrades to existing building utilities, like electrical power and related controls, and other things)

    + Planned capacity expansion to our Burr Ridge facility

  • Another thing I would like to address on the June 30th balance sheet is the Company's roughly $1.7million dollars in long and short-term debt. 74% of this, which is currently classified as long-term, reflects the previously disclosed $1.3million loan from a customer.

  • Lastly, we have also had significant increases in accounts payable. This is mainly a function of both the Company's capital-spending plan and the inventory build.

  • Given the current outlook, we plan to exit this year with $7-8 million in cash and investments. Based upon the visibility that we now have, we have more than enough cash to fund our business plan through 2002 and for the foreseeable future.

  • Thanks for your attention, now I'd like to turn things back over to Joseph Cross, our President and CEO.

Joseph Cross, President and CEO

  • This past quarter, and indeed the first six months of 2001, has been characterized by significant technical successes and technology growth throughout the company. Increasingly, we believe, the company has lengthened its lead in nanocrystalline technology, application development, and commercial manufacturing of nanosolutions. We are not aware of any other company with even remotely similar capability. This technology and leadership continues to be the company's core strength, principal value, and foundation for future growth.

    • We have been able to essentially achieve our stated manufacturing cost reduction goals for 2001 in the first half of the year. Based on the break-through we have achieved in the PVS process technology, we expect to achieve an equal amount during the second half, essentially doubling our stated reduction goals to achieve at least a 30% manufacturing cost reduction. This break-thru, coupled with our recent drive to lean manufacturing, also provides a solid foundation for continuing manufacturing cost reductions during 2002.

    • Another result of this series of improvements has been a significant increase in output per reactor. As we continue to implement these on all of our equipment, we expect to increase output per reactor from 50-100% from our baseline position. Stated another way, from our baseline start at the beginning of 2000, we expect to achieve increases in output per reactor up to 4 times the baseline rate.

    • Thirdly, these changes have provided significant product quality improvements in particle size control as well as increasing the purity and quality of our materials. We believe that this will have an appreciably beneficial impact on penetrating markets for certain applications as we go forward.

    • The second area of technical innovation has been in our application science where we have experienced several breakthroughs relative to our target markets. As an example, we have recently developed and announced the technology to suspend our nanocrystalline materials in an extensive range of liquids, which has direct positive impact for transparent functional coatings, catalysts - including catalytic fuel additives, heat transfer fluids, and slurries for a variety of applications. We have also achieved breakthroughs in other areas that we cannot address until we are able to protect the intellectual property.

    • The last significant area of innovation has been in commercializing our new nanocrystalline manufacturing process, Audrey, which we view as complementary to our core PVS process. During the first and into the second quarter, we successfully established the process capability to produce multiple materials, including mixed metal oxides, at highly competitive cost and production rates. Beginning this quarter, we will begin to commercialize materials in a priority dictated by market demand. We do not expect the Audrey process to significantly impact revenue until possibly late fourth quarter or early 2002.

    • Quite obviously, despite what we perceive is a very difficult economic environment, the company is extending its lead in nanocrystalline technology, including commercial manufacturing. That is, we believe, the real value of Nanophase - the intellectual property and proprietary knowledge in an emerging science with vast potential and multiple market applications.

  • Another large area of focus and effort for the company has been to complete the construction and implement a production coating facility, primarily for our largest sunscreen customer, and a pilot manufacturing facility to be able to deliver nanocrystalline materials in dispersions, coatings, and formulations to our target markets and customers. The coating facility is beginning operation as I speak and will be producing the initial qualification lots for our customer over the next 30 days. During the remainder of the year and into early 2002, we will be building production volume in the facility, which will reduce our dependence on a third party contractor and increase margins.

  • The pilot line facility, which is scaled to produce moderate commercial quantities, is in the final stages of construction and is expected to be complete and operational in the August/September timeframe. This capability is vital for Nanophase to penetrate certain markets and grow revenues over the next 2-3 years.

  • Regarding revenue for the quarter, obviously we were unable to achieve the quarter-to-quarter revenue growth that we expected, largely due to exiting an exclusive relationship with a European customer for catalytic fuel additives that impacted expected sales this quarter by at least $530,000. Frankly, their inability to honor their commitment for the second quarter was a factor in that decision. However, we believe that this was the right decision for the company for the long-term horizon. We are proceeding with rigorous testing of the materials and have formulated a tactical plan to align Nanophase with the proper partners to explore this application and define a prudent path to the market. Dr. Freed will cover this topic in more depth later in the conversation.

  • Before I turn this over to Gina for an update on our other technology initiatives, let me address one last topic that seems to have caused concern in the investment community. As many of you are aware, three Officers and one Director sold some stock this past quarter.

    • In regard to the Officers, first, stock options are a form of compensation in this company. In each case, the Officers involved had personal reasons for their decisions, as is their right to manage their own compensation. While the timing turned out to be awkward, related to our decision to exit the relationship with the European customer, all the factors that led to that decision were not known until literally hours before the press release. As soon as those factors became known, the company imposed an immediate internal blackout and all insider activity ceased.

    • Secondly, the Officers and key Managers of this company are completely vested and in tune with the aspirations of the stockholders. Despite the message board rumors, I personally have not disposed of all of my stock options and, as publicly filed, hold about 400,000 options. The key Nanophase team holds over one million options, as reported openly in our public documents, and is fully confident in the company's future, the power and multiple applications for nanocrystalline technology, our leadership position in this emerging science, and the probability of stock appreciation. To put this in perspective, the Officer sales amounted to only 3% of the options held. By another measure, it was only 0.3% of the outstanding shares. In my own view, the concern I personally received from the investment community seems out of proportion to the size of the event.

    • Concerning the sale by the Director, who retired from the board, his stock option grants only allowed a 30 day period from leaving the company or board to exercise options or the grant is cancelled. Obviously, the retiring Director chose to exercise rather than lose the option value.

    • Lastly, in the future, there will undoubtedly come a time where certain Officers for their own personal reasons may choose to exercise options and manage their compensation. The investment community should not leap to the conclusion that such a decision implies any lack of confidence in the company's future. Insiders exercise options constantly across all industries - in fact, June of this year was the largest insider sales month in quite some time according to the media - and they seem to do so largely with little or no outcry. Nanophase insiders should not be held to a tighter standard.

  • Now, let me turn this over to Gina for a summary of our technology progress.

Dr. Gina Kritchevsky, VP of Technology and Engineering

  • Thank you Joe,

  • Good morning, I want to update you on the tremendous progress that Nanophase had made over the last quarter in both R&D and Advanced Engineering and discuss a bit about our plans in these areas for the third quarter.

  • We are continuing to focus much of our effort on several aspects of our Audrey process. We continue to make improvements to the subsystems of our pilot Audrey reactor. These modifications will contribute to reducing overall system and product costs for our production Audrey materials. The second area of concentration is the development of full commercial processes and data for selected Audrey materials. The third is a continued screening of new potential materials for the Audrey process. During the second quarter we successfully manufactured mixed metal alumina-silica materials and mixed rare earth oxides.

  • Due to the differences in the PVS and Audrey processes and in the feed materials, some products can be produced more efficiently on Audrey and some on PVS. The primary purpose of Nanophase's Audrey process is to expand the variety of materials that Nanophase offers and the secondary purpose is to reduce the cost of producing these materials. Although the Audrey process has demonstrated some substantially lower cost feed materials and higher production rates, we have also made tremendous progress reducing PVS costs this year. I expect that in future years, Nanophase will be using more than two or three processes to produce our nanoparticles.

  • Next, I would like to describe another new engineering initiative, our Advanced Engineering Laboratory. The strategic value of this laboratory is to allow rapid penetration of new markets through the ability to quickly produce initial quantities of new materials for market evaluation. Initial goals are aimed at developing new non-oxide nanoparticle powders for customer evaluation, to continuously improve existing nanopowder production processes, and develop new dry powder treatment processes that add value to Nanophase nanopowders.

  • Construction of the Advanced Engineering Laboratory Reactor is underway at the Romeoville facility and initial operation will begin late in the third quarter of 2001. The new reactor will ultimately combine elements of PVS and Audrey with greater control of the reaction conditions to develop processes to produce non-oxide materials to expand the pallet of the nanopowders currently produced at Nanophase. The first project for the reactor will be production of large quantity samples of two new High-Performance (HP) nanopowders for trial in emerging applications. Projects will include the production of nanosized metallic powders and the development of non-oxide nanopowders including nitrides and carbides. The reactor design is highly modular, allowing reconfiguration and enhancements as development needs dictate.

  • In the R&D and applications development area, we have made substantial progress in improving the properties of our dispersions and coating formulations. We have done this through work on several fronts; our new high performance HP materials demonstrate narrowed particle size distributions, new technology to produce stable dispersions of nanocrystalline metal oxides in organic resins and solvents, such as alcohols, hydrocarbons and fuel oils. This development allows Nanophase to suspend its nanocrystalline materials in an extensive range of liquids to address a wide range of customer applications and a newly developed ability to modify the surface chemistry of the nanoparticles by vapor phase post reactions. We have filed an application for patent coverage for this new dispersion technology.

  • To summarize our developments and progress in technology and R&D and application engineering over the quarter; we have improved the PVS process to achieve both rate and cost improvements for all our current PVS products. We are also continuing our successful development of the Audrey process and products, which are complementary to PVS and will provide new nanomaterials for Nanophase. Both the new commercial scale coating facility and the pilot dispersion and coating facilities are nearing completion. Finally, in the application development area, we have made substantial breakthroughs this quarter in the development of technology to disperse and compatiblize our nanopowders into numerous solvents and polymers, which enable us to bring more value to our customer's products.

Joseph Cross, President and CEO

  • Thank you, Gina. Dr. Don Freed will now address business and market development initiatives.

Dr. Don Freed - Vice President, Business Development

  • Good morning - and thanks for your interest. As part of our business development activities, and because Nanophase is receiving a lot of interest in catalyst developments, I thought I'd spend a brief moment covering our activities in that area.

  • As we announced previously, we are vigorously pursuing our catalytic fuel additive strategy - and I'd like to explain why this is so important. As you know, the Company currently supplies nanocrystalline materials for use in automotive catalytic converters where because of their unique crystal structure and high surface area they improve converter efficiency. We believe that similar improvements will also be gained by introduction of these kinds of materials directly into both gasoline and very importantly, fuels for diesel and two stroke engines, which we believe could have a substantial impact on vehicle emissions reduction.

  • We are also in the process of testing and evaluation of our catalytic fuel additive at Ricardo Consulting Engineers, one of the premier engine/fuel consultants in the world and one used by many engine and fuel companies. As we recently informed you in our last press release, we have also filed for patent protection for our inventions relating to this technology. Upon completion of our testing we expect to initiate discussions with potential partners both in industry and government. We also expect that these potential partners will want to make their own independent evaluations. Since this program will take some time, we do not expect sales in this area much before this time next year. Obviously, in order to protect Nanophase's interests in this field, we cannot say more than I've told you today however, when we can, you will certainly be informed.

  • Interest in using the Company's unique nanomaterials remains high; in fact we have more opportunities in the pipeline now than at our last call. However, the serious global economic slowdown is severely impacting our time-to-market - what we are seeing in the business development area are customers taking a lot longer to evaluate our products, for example just last week, two customers informed us that plant trials with our materials, which we had expected to occur in late July, would now not take place until mid-August. Remember that our product development cycle has several key steps at the front end - in particular value assessment and initial customer evaluations - and of course, a change in schedule will happen occasionally, but when it becomes a frequent occurrence, you can tell that the global recession is having a widespread effect.

  • So what are we doing about it? Well, to begin with, we've about doubled the number of opportunities and programs that we're working on - and because when a program experiences delays such as I mentioned in the case of the plant trials, our R&D staff has time to tackle additional programs. Many of these new programs are in the same focus areas of personal care, abrasion-resistant coatings, environmental catalysts and thermal spray, so that we can use our already developed know-how and technology effectively and quickly.

  • However, there are also several new programs where the benefit of our nanocrystalline material is only realized if the Company supplies a slurry or dispersion of particles. In the past, we could only supply these materials in laboratory quantities. We can now take advantage of our new Pilot Line capability to supply sufficient quantities of product for initial evaluations by potential customers as well as ongoing small-scale or quick turnaround production - for example we have a number of customer plant trials pending in the wear-resistant fabric and anti-static coating areas. Customer requirements for these applications
    are well beyond laboratory scale and we see the Pilot Line as enabling Nanophase to expedite customer adoption.

  • Secondly, we've increased the number of joint programs that we're cooperating on with the C. I. Kasei subsidiary of Itochu, our Japanese licensee. Although Japan has also been affected by the severe economic slowdown, our tactics here should help us.

  • We've also just brought on the former vice president of marketing of a major chemical company as a consultant to help us develop additional business opportunities. All of these steps are designed to increase the opportunity and reduce the time needed to get to production.

  • Now, I'd like to turn it back to Joe Cross…

Joseph Cross, President and CEO

  • Thank you, Don. Dan Bilicki will now summarize our marketing and sales activities.

  • Dan Bilicki, VP Sales & Marketing

  • As reported, revenue from Q2 was $1 million 49 thousand with $957K or 91% being derived from sales of products. This is essentially in line with Q2 of last year.

  • A critical success factor for Nanophase is building relationships with lead customers within many diverse industries that will allow us to capture the business while providing cost effective products or processes. The skill involved in choosing lead customers is finding one with an unsatisfied need, an internal champion, and a lead customer that is playing offense rather than defense.

  • The business plan for 2001 was assembled during the fourth quarter of last year when many lead customers where playing offense and our time to market objective was decreasing from our target of 12 to 18 months. Also during this time in the manufacturing area there was a significant level of confidence and interest in exploring new science and technology. Over the last six months, a global economic turndown has resulted in layoffs, budget cuts, and a lessening of confidence, this has impacted Nanophase primarily by increasing our time to market.

  • As you have just heard from Don Freed, the level of business development activities remains good. However, we have experienced a serious slow down in the speed with which these opportunities are being evaluated and turned into product sales. The time to market slowdown caused by uncertain economic times further clouds our already limited visibility making the forecasting process very difficult.

  • An overview of our product sales progress by key market segment for Q2 as well as an outlook for Q3 follows:

  • In the Personal Care market segment product sales for the first six months of 2001 were 10% ahead of last year, but still lower than our original expectations. The ZnO surface treatment system has been mechanically completed and following the commissioning phase, product will be available for shipment in August.

  • During the Q1 conference call we mentioned that Nanophase had two non ZnO Personal Care initiatives underway. The application in the trial stage has been delayed due to customer resource allocation and will not launch until Q1 2002. Due to economic concerns, the customer has delayed the decision on the second application until Q4 of 2001.

  • On the positive side, Nanophase has received its first ZnO purchase order for a new product launch involving a printing application.

  • Recent breakthroughs in our ability to disperse nano-crystalline materials in various media have further extended our product capabilities in the transparent functional coating area. As a result of our collaboration with our Japanese partner, Nanophase will begin to offer a range of highly dispersed nano materials that have a narrow particle size distribution with uniformly small particles. ZnO dispersion is currently being utilized by a Japanese lighting manufacturer for UV attenuation. The polishing of glass semi conductor masks represents another market opportunity for these high quality dispersions.

  • In the Catalysts area Nanophase has a number of new products under evaluation by our catalytic converter customer. Test results for these new products were expected in June, however due to delays the results are now promised for the end of August. As reported testing of our catalytic fuel additive is currently underway. Upon completion of the test work and evaluation of the results Nanophase will begin active exploitation of this application in both the commercial and governmental sectors.

  • In the ceramics market good progress has been made in the thermal spray market as Nanophase has developed new products including chrome oxide that are currently being tested.

  • In Summary: Q2 product sales where essentially in line with product sales of last year. Product sales for Q3 are expected to remain flat with respect to Q2.

Joseph Cross, President and CEO

  • Thank you, Dan.

  • At this time, I would like to address our expectations for third quarter. As both Dan and Don have indicated, Nanophase is being impacted by the rather severe, sudden, and steep global macro economic slow-down. This is reportedly the most acute in the manufacturing, or product-based, sector that represents our customer base. The US manufacturing sector is reported to be at an 18 year low. If one compares the macro economic environment during the last quarter of 2000 when we built revenue expectations and business plans to those currently existing, and maybe even worsening, there is a dramatic difference in the landscape.

  • For example, we have encountered sales into the semiconductor industry For example, we have encountered For example, we have encountered sales into the semiconductor market sliding 1-2 quarters; sales of abrasion resistant coatings for the flooring market turn slightly downward; sunscreen material volume, as announced earlier, increased less than originally forecast by the customer; and personal care nanomaterials are below the customer's forecast. We have been surprised and frustrated by the worsening market conditions over the past two quarters and are not optimistic on the view for the next 1-2 quarters. We do not view the sales revenue as lost, but simply delayed.

  • Another definitive impact on Nanophase is a definite lengthening of our business development cycle due solely to the various market situations and increasing restrictions our customers are experiencing. This is impacting the timing of product revenue and is undeniably impacting our visibility on the timing of future revenue. Quite definitely, we are trying to achieve market penetration and revenue growth in a very difficult macro environment that is not conducive to our timetable. As an example, many of the situations that we expected to close during the second quarter have moved into the third and beyond.

    • We are implementing a broad series of actions to increase our business development and sales activities. At the same time, we are containing cost and seeking opportunities to reduce cost across the organization without taking draconian measures that would affect or jeopardize the company's future.

    • We now expect third quarter revenues to be essentially flat to this past quarter. At this point in time, we are unable to solidify fourth quarter estimates, or the full year, due to the uncertainty in the economy, various manufacturing sectors, and our target markets. However, based on recent customer guidance and our current assessment of market conditions in our target market groups, we now believe that 2001 annual revenues will be in the range of $5-6 million, or a 20-40% increase over 2000. Naturally, we are displeased with this assessment versus our original expectations for 2001 and are making multiple efforts to improve revenues. We obviously cannot predict the extent of our success in this regard considering the general uncertainty in the manufacturing sector.

    • We forecast sales forecast based on customer commitments and input. Especially in the business development area for new products and new customers, our customers seem to either have no visibility or flawed visibility, and either are unable to predict or have demonstrated that their predictions are suspect. For that reason, our visibility is equally as limited and current information is suspect. We have many initiatives in process, including customer plant trials, on our proprietary materials that may have an impact on 2001 and definitely 2002. We will continue assessing both 2001 and 2002 revenue expectation and provide guidance when we are comfortable that we can be reasonably accurate.

    • Let me leave you with one last thought. Despite the very difficult macro economic environment, which most of you have been around long enough to recognize and assess as well as we have, Nanophase continues to lead the technology revolution in the nanocrystalline materials world. Our progress in technology and accumulating intellectual property and proprietary knowledge is strong. That, to me, is the real value of this company. The revenue will come, a little slower than we all thought due to economic conditions, and this company has the technology leadership and talent to succeed.

    • This concludes our prepared comments. Let me remind you that our comments will be available on our web site, www.nanophase.com, on or about Monday, July 27. We will respond to any questions you may have at this time.

     

    SECOND QUARTER CONFERENCE CALL 07-26-01
    QUESTIONS & ANSWERS

Operator: Thank you. Ladies and gentlemen, at this time if you have a question you will need to press the one on your touchtone phone. You will hear a tone acknowledging your request. Your questions will be taken in the order that they are received. If your question has already been answered you may remove yourself from queue by pressing the pound key. If you are using a speakerphone, please pick up your handset before pressing the button. One moment for the first question.

Doug Moffat, please state your company name followed by your question.
Doug Moffat: Yes, Robinson Humphrey. Good morning.
Management: Good morning, Doug.
Doug Moffat: A couple of clarifications, if you will. When you talked about inventories to begin with, you made several comments, one about lowering the cost of inventories and then about the raw material component of inventories being up by $350,000 and so I'm a little confused. I wonder if you could expand on that? I guess I'm not quite sure of the significance of the inventory write down and why that is necessitated. And then maybe what the work off period will be for this, I guess in total, the $600,000 of additional raw material inventory?
Jess Jankowski: Doug, this is Jess Jankowski. The workout period is unclear, it depends on acting CFO & Controller how the business unfolds. The $350,000 is a combination of both raw materials and finished goods that was built to support anticipated volume, not just for the second quarter but also the balance of the year as is the additional $300,000 coming in next month and that's because of the lead time being so long and the volume being so large. The write downs have nothing to do with value, they have to do with our cost of production. We effectively analyze our standard costs, most of the cost saving measures we've put in are now fully in production in the second quarter and we decided that the prudent thing to do would be to bring the inventory values that are sitting on the balance sheet down to a level that equals what it costs to produce the material.
Doug Moffat:  
Okay. And then also on the increase in the doubtful accounts, who is that customer? Is that the European catalyst customer that's not taking material? And whomever it is, is this fully reserving this customer?

Jess Jankowski:
Acting CFO & Controller
At this point we can't discuss the exact customer. It's not fully reserving the customer but the majority of the potential is covered and we think we're in a very conservative position.
Doug Moffat: Okay. And then I wanted to ask a little bit about the fourth quarter prospects. I understand your visibility is far from clear here on the fourth quarter, but it sounds like you're thinking that sales from the third to fourth quarter can potentially ramp up quite a bit here to better than $2 million. Can you talk about what the deltas that you're hoping for would be to get you there?
Dan Bilicki:
VP Sales & Marketing
Doug, this is Dan Bilicki. We've, as indicated, looked at Q3 and see that it's probably going to be in line with Q2. However, there are some very interesting potentials that are coming through that we hope to see bring Q4 up to a level that matches our expectations for the year.
Doug Moffat: Can you just give me some flavor for what has to happen at customers and so forth to make that happen?
Dan Bilicki:
VP Sales & Marketing
Several of these planned trials that have been delayed are now finally going to be happening in Q3. We're very hopeful that as a result of that we're going to see the benefit in terms of additional sales.
Doug Moffat: I'm more interested in just what kind of activities at the customers and so forth have to happen for that sales increase to develop. I guess what Dan was saying is that there are trials out there that can finally happen and then I presume there would be commercial business developing immediately right after that.
Dan Bilicki:
VP Sales & Marketing
That's correct. As you know, in our process we start with concept, move into trial and then we move into pre-production. In several of these that we hope to happen earlier this year are in the major trials stage and those have been continually backed off, but we expect those to happen in August. So we're hopeful that once they do happen we'd start to see the benefit of those trials move into the sales side.
Doug Moffat: Then, just one final question and I'll get off here. In terms of the new improvement in the production process to allow you a tighter size particle distribution, etc., how long will it take you to benefit from that in the marketplace? Will it take some period of time for customers to evaluate the new improvements, etc.?
Dan Bilicki:
VP Sales & Marketing
Those new improvements, what we've done, Doug, is we did a stroll back through the history of Nanophase and looked in our archives and said, well, there was this customer that wanted this particular application that we just couldn't quite meet their requirements. Now with this new technology we're going back and reopening those opportunities to see whether or not the new material will actually provide the benefit that the customer is looking for.
Doug Moffat: So is it like a six-month process to get traction?
Dan Bilicki:
VP Sales & Marketing
Yes, it is. Because we'll start it a little faster than we are normally able to start.
Doug Moffat: Okay, good. Thank you.
Operator: Loren Ben, please state your company name followed by your question.
Loren Ben: CIBC Oppenheimer. Good morning. A lot of the questions have been answered but why do you file so many press releases telling us about all this new technology? As I said, I think you've answered quite a bit of it.
Joseph Cross:
President & CEO
Loren, this is Joe.
Loren Ben: Hi, Joe.
Joseph Cross:
President & CEO
 
We're trying to adopt more of a guerilla marketing approach, frankly. While those of you on this call know who we are and what we do, there are a lot of people out there who don't and we're trying to expand our reach into several other key markets, primarily in electronics. So we've adopted a strategy of trying to make product announcements when it seems proper to do so. Those are also released through industry journals. For instance; on the product release for the HP materials that we put out a couple weeks back, that's already been picked up by several industry journals like Chemical and Engineering News and others. We've got several customer calls, in fact we had about six yesterday who read that article and called us to talk to us. So part of the reason we're announcing that is not so much to the investor community, it's more for potential customers and trying to get our name out there into broader circles and to create more opportunities for the company.
Loren Ben: Fair enough. The second question would be, as you develop these new technologies and you're looking for applications, do you have a batting average as to when somebody comes to you with an idea and you think you have an application or you have the ability to develop something? Do you have an idea of whether you can hit 20% of them, 30% of them?
Don Freed:
VP Business Development
Loren, this is Don Freed.
Loren Ben: Hi.
Don Freed:
VP Business Development
Hi. 30% would be spectacular. But part of it, the goodness of the batting average depends on how good we are at evaluating and valuing it to begin with. We get a lot of calls, there's a lot of opportunities and we spend most of our time in the early days trying to figure out (A), is there value for the customer or potential customer and (B), is there value to Nanophase? Those have to click before we can get even to the concept of the batting average. When we're good at doing that, we're probably seeing between 10% and 20% of these things move down the pipeline heading towards ultimately getting into commercial business. That's not a bad batting average as high tech companies go. I've never seen anyone do much more than 20%. If you're doing more than 30% it's magic. It's hard to know, so I think we're doing a pretty good job but it's only as good as our up front screening.
Loren Ben: Okay. And the last question, regarding your pipeline, A pipeline has to be filled up, you have to stuff in one end before it comes out the other end and the question is how close are you to having stuff coming out the other end on a steady basis?
Don Freed: VP Business Development I think it's back to the concept of the question that Doug answered. There is stuff all along the pipeline. Obviously there's more at the front end of the pipeline because things fall out. But there is a stream of product applications at the other end waiting for a lot of things, including the plant trials that both Dan and I mentioned and customers making final decisions. Of course that's being impacted by the sort of bunker mentality that a lot of companies have adopted, particularly with our customers because we sell largely into the manufacturing sector. So the opportunities are there, it's just difficult to have visibility on the time at which they'll pop out.
Loren Ben: So when the economy does turn the corner you expect the spigot will open up a little bit faster than it is now certainly?
Don Freed: VP Business Development Yes, we do.
Loren Ben: And do you think you'll be ready from the manufacturing standpoint; will you have enough plant and equipment in place to meet the demand?
Joseph Cross:
President & CEO
Loren, this is Joe. Yes, I think so. With the improvements that Bob and his team have made this year, we've really increased the output per reactor. If you look back since maybe the day I walked in the company, which is my first shot at looking at the company, at that time in place, we had one reactor per operator so there was a human on every reactor we were running. Right now we're up to about six reactors per operator.

So we've made a lot of progress relative to the amount of staffing we have to provide for a reactor. We made a lot of progress in output, so essentially we reduced our capital needs going forward in some sense relative to reactor costs or adding reactors for capacity. So right now to the best of our knowledge, and again our visibility is nowhere near 100% perfect, essentially we feel like we're in pretty good shape from a reactor standpoint for next year. Again, we achieved several gains over the last six months and a little bit previous to that even in getting very good at manufacturing nanos. In fact, I think that's one of our core competencies. We really have learned how to manufacture nanocrystalline materials.
Loren Ben: Okay, great. Thanks very much.
Operator: Steve Springer, please state your company name followed by your question.
Steve Springer: Yes, Target Capital. I'd like to ask a question regarding time to market. In the past, the time to market has been discussed as something like 12-18 months and it just seems as if we've hit the wall here in a hurry and the business outlook has changed dramatically from guidance earlier in the year. I wonder if you could discuss a little bit about what kinds of commitments you're actually negotiating with these companies? For example, we have $300,000 in raw materials that came in for fuel additives in the quarter, another $300,000 coming in the third quarter, and I'm wondering what ... those raw materials were purchased against some sort of indication that there was going to be an order. I'm wondering what kind of an order is that?
Joseph Cross:
President & CEO
Steve, this is Joe. Let me address that. In that particular instance this had been a discussion between Nanophase and a European company that goes back well into at this time last year. The reason we ordered that material was due to the following. During the development negotiations both companies had signed a memo of understanding and this memo of understanding was very explicit and part of the details listed specific quantities, specific deliveries and specific timeframes according to the customer's schedule. Now a memo of understanding is not binding. We had taken that memo of understanding and had it put into a legal agreement, which was in front of the customer who had assured us they were going to sign the legal agreement until right at the end. So because of the lead-time on this material, which is about four months, based on the memo of understanding the company had reached with the customer and indeed, the legal agreement that the customer verbally said was okay, we had to order the equipment in order to meet the time table, I mean order the material in order to meet the time table, so that's what we used as a basis. Frankly, a memo of understanding and a legal contract that specifies material deliveries is a pretty solid basis on which to forecast normally in my experience, although this case did not turn out that way.
Steve Springer: It didn't turn out that way because effectively the client reneged on a verbal agreement?
Joseph Cross: I don't think the client reneged, but I think the net effect is that's probably President & CEO true. What I think really happened is the client is totally undercapitalized to make the agreement. I think the client expected to have a certain level of capitalization by the time it came to signing the legal agreement. Our perception is they did not have the capital in place and could not live up to the agreement, which was the first indication we had frankly that they were undercapitalized because they had led us to believe they were highly capitalized.
Steve Springer: Yes, okay, well just to beat this to death, under these circumstances why is it that we're protecting this entity and not disclosing who it is? What have they done that has earned that respect as opposed to the way that they've treated Nanophase?
Joseph Cross:
President & CEO
Let's say they've acted in a fashion that we've lost a lot of confidence in them. We are following a process that has been recommended by our legal counsel and that's exactly the process we intend to follow in this instance.
Steve Springer: Okay. I mean, I just find that we're in a situation where there's a great deal of secrecy requested by putative clients.
Joseph Cross:
President & CEO
Oh, I understand that this is a multifaceted topic, not just related to orders and excess inventory for orders that failed to materialize. We're acting, as I said, on the advice of legal counsel and that's the process we intend to follow.
Steve Springer: Yes, I'm not quarreling with that, Joe. I think you've answered the question, but I'm just saying that in general when we talk on these calls about new business applications, what industries they go into and other details, there's a great deal of secrecy surrounding these discussions. And many of these projects get pushed out and out and out and of course you're guiding based on your best indications, I understand that. Clearly, the economy has fallen off a cliff in some areas, it's just been a very rapid slowdown. So I don't have a quarrel with you in that respect, but I'm just saying that there's a paucity of information and we're in a vacuum. And so to the extent that you can make more information available I think it would be helpful. But I'm not quarreling with the management and what you're trying to do here and I recognize that it's a very difficult situation.
Don Freed:
VP Business Development
Let me answer that, Steve, this is Don Freed. There's two reasons.
Primarily one is, as we've mentioned before, customer confidentiality is important to our customers and they request it because we're giving them a competitive edge that they don't want their competition to know about. But more importantly than that is the field of nanotechnology has grown at an amazing clip and there's a huge amount of awareness out there. There are potential competitors out there following every move that Nanophase makes, they read our press releases, they listen to our conference calls, they're all over our website. We do not intend to point the way for potential competition to either go to a named customer or more importantly, a named application and so we do it to protect our interests, your interests, the company's interests, everyone's. We can't be in the position of pointing out the way for potential future competition so we have to maintain secrecy.
Steve Springer: Okay.
Dan Bilicki:
VP Sales & Marketing
Steve, this is Dan Bilicki and I'd like to throw in one more bit here. In the past there were discussions and press releases about companies that Nanophase may have been doing some development work with. And really development is a very, although we try to minimize the amount of risk associated with it, it's still very risky in terms of the customer's input and our input. So rather than go out and talk about all these things in the development stage, we want to get beyond that and we want to be able to talk about contracts and business, not development.
Steve Springer: I'd just like to ask one other quick question. To what extent do you believe that we are developing products that offer a compelling cost benefit to the extent that as we go forward companies will see that there is a compelling benefit to them to introduce the product regardless of whether or not GDP is growing at 1% instead of 3%?
Joseph Cross:
President & CEO
Steve, it's Joe. I think in a couple of areas that we provide immense value. The people who have worked with our abrasion resistance materials, frankly, are constantly surprised at the property they get and what they think it will do for them in the market. We had another situation that just happened yesterday where a customer ran an initial evaluation of our product, our abrasion resistant coating, on their particular material and they were just surprised and excited and we're going forward. So I think in abrasion resistant coatings and in transparent functional coatings we bring a lot of value.

We really believe we've got some real opportunity in thermal spray, we've made some breakthroughs in thermal spray this quarter that have been very significant and very surprising. We're trying to come up with a path to get this better to the market than we've been able to in the past. Environmental catalysts for this company are a very strong growth area. But in each of these cases, it takes time to get the data to prove to people the value of the application. While people here know who we are, like I said before, there are a lot of people out there who ought to be buying from us that have never heard from us, that's why we're trying to increase our marketing and get our name out to a broader sphere of companies. So I think that we're on the cusp of achieving that in several critical markets to be really frank with you. We're pretty excited about those markets.
Steve Springer: Okay, thank you.
Operator: Ladies and gentlemen, if there are additional or follow up questions, please press the one at this time. Remember to pick up your handset before doing so. One moment for the first question.

James Liberman, please state your company name followed by your question.
Jay Liberman: Yes, Tucker Anthony. It's more of a comment and observation than it is a question but it may evolve into a question. What I think I'm hearing is basically the cusp or the introduction of a new industry of nanomaterials. I think that's what you've been trying to say and I feel that some of the questions miss the point of what's happening here.

What it appears to me is that any transition like this is going to take a varying degree of time, which is somewhat unpredictable. But rather the observation is that any transition because of the indeterminate time has to be understood in that timeframe. So whether it's a quarter or two that you're missing, a prediction that you made that was maybe viable a year ago is really insignificant compared to where it's going. It just seems to me that focusing on quarter-to-quarter is missing the point and missing the great opportunity that's there ahead of us and I think this is a great opportunity. I'm more excited now by the technological breakthroughs you've made and the positioning in the marketplace because if anyone decides to create a new material in the laboratory, who are they going to come to produce it? It's not just the materials that you're doing, it's where you're positioning in the marketplace and I couldn't be more pleased with where we are right now. So that was my comment, if you want to comment on my comment, that's fine.
Joseph Cross:
President & CEO
I'll comment on your comment since you commented on our comments. Look, we feel the same way, whereas we're frustrated with the revenue picture, we're equally as excited with the technology breakthroughs this year. Most of the technology breakthroughs that we talked to you about are like the tip of the iceberg, because we're not talking to you about the other 90%. One, we really don't want it out in the public domain right now. Two, we're working with at least two Fortune 100 companies on nanotechnology initiatives that they have and we're looking at and we're working together on that. We can't say much more than I just said about that because we have an agreement that says we won't. So there's a lot of technology in this company. We believe that this technology is very powerful. So the fact of the matter is we think this is a long-term proposition.

Now we're a little frustrated with the economic situation and we're a little frustrated with the fact that we deal with a lot of big companies who move at glacial speed and for whom a quarter is a measurement of time, because for us an hour is a measurement of time. So in this kind of economy, frankly, the glacial speed is even getting slower if it's possible. So we still believe in the power of this technology, we think that this company has amassed an incredible amount of intellectual property, especially in the last six to nine months, we've made some huge breakthroughs and we have some things happening that we haven't announced that are equal in power, we believe. So we think this market's definitely going to come, there are multiple market applications for this. It's tough for 55 people to address all these markets and all these opportunities and that's just the way it is. We're trying to take our best shot at what looks to be the most powerful and we think we're doing it.
Jay Liberman: Thank you very much.
Operator: Donald Hutchinson, please state your company name followed by your question.
Donald Hutchinson: Merrill Lynch. Anyone could answer these questions, I guess. I heard before a comment that the lost contract with the automobile or the fuel catalyst has a chance of reviving. Any comments on the possibilities of having that resurfacing in the fourth quarter here?
Joseph Cross: President & CEO This is Joe Cross. We think there's a probability for that. We're going on what the potential customer is telling us. But again, we're a little less confident in this customer than we have been in the past and definitely it will not be an exclusive relationship, it'll be a non-exclusive relationship. But the customer maintains that we're the only place on earth they can find this material and we believe they're accurate based on our testing. They've indicated they're going to continue the relationship with us totally on a purchase and supply agreement basis and they may come back and need more material in the fourth quarter, but we have to see that happen first.
Donald Hutchinson: Are they still actively engaged in testing or using it or doing whatever they were doing?
Don Freed:
VP Business Development
Yes, this is Don. Yes, they have a program, they're moving forward albeit at a probably slower rate, because as Joe said, they are under capitalized but with the proper protection we believe that it's a potentially viable customer. As I said at the outset, and as we told you before, we've adopted a non-exclusive strategy for the catalytic fuel additive. And that means that offers us broader exposure, it caused us a little pain but at the end of the day we think it's the right strategy.
Donald Hutchinson: I made a note to the effect that there were some test or another with a new material involving automobiles, not the environmental catalysts that was supposed to be done around June. Could you elaborate on what happened with that?
 

Dan Bilicki:
VP Sales & Marketing

This is Dan Bilicki, Don. What we were referring there, in my comments is that we expected the test results from this in June and that was the initial thought from the customer. He has since revised that and indicated to us that it won't be until August or at the end of August and we've now scheduled a meeting with the customer around the 22nd of August.
Donald Hutchinson: Okay. So this particular material is not the stuff that's being currently used cerium oxide?
Dan Bilicki:
VP Sales & Marketing
No, it's a unique material that they had in a test that lasted for almost six months.
Donald Hutchinson: Okay, that's it. Thanks.
Operator: Todd Cobey, please state your company name followed by your question.
Todd Cobey: Cobey, Jacobson and Gordon. I had a couple of questions. First, could you address the $400,000 growth in the first six months of the year in SG&A? Perhaps tell us how much of it is sales, how much of it is administration?
Jess Jankowski:
Acting CFO & Controller
This is Jess Jankowski. Most of that is administration and not sales. Much of that relates to the addition of Bob Haines as our VP of Operations as well as relative moving expenses for him. And we don't expect most of that to recur.
Todd Cobey: Okay. Second, I wanted to get some context to the questions, which my colleague from Tucker Anthony had thought was misplaced. I think everybody on this call who follows the company is impressed with its technological abilities. But many of us have seen a dozen companies that have had excellent technologies that were unable to convert them into meaningful commercial success. The one that we're probably most familiar with would be that Apple always had better technology than Microsoft. It's the conversion to marketing and sales, which meant the difference in many companies, as we all know. So that I think is one reason that that's so much of an emphasis on the call. We think you've done splendidly in the other areas.

I wanted to direct it to the company's posture in negotiating some of these agreements in terms of confidentiality. I know the customers ask for it, I've done some of that myself. They always ask for it, but it never seems to be a deal breaker if they really want the product or the materials. And from the company's side, Dr. Freed mentioned that he didn't want to tip his hand to the competitor. It's been my experience that competitors always find out about what you're doing anyhow. I think that if you were able to announce some of these customers, it would play into the concerns that Joe mentioned about getting the name of the companies around and making a greater number of customers aware that we have these products. There's nothing like picking up a paper and seeing that somebody who is a competitor or in the line of business has signed a contract with somebody to get your name around. I think especially if we're as far ahead of the competitors as I've heard on this call, in this call and other calls of the quarter, it wouldn't be as damaging to our competitive situation if we could take a more aggressive stance and said we don't want confidentiality. It's in the interest of our shareholders and in the interest of the companies position in the marketplace to let people know who we're dealing with. That also could be said for exclusivity in terms of contracts but that's another issue.
Joseph Cross:
President & CEO
Let me address those points. When we all first came here is a couple of years ago, we found ourselves confronted by the situation that existed, frankly, and we thought that we had to build up a base of business. Now part of the cost of that for an unknown entity with a couple of these customers has been exclusivity. None of us are real excited about exclusivity, it's not a path that we like. I think that if a customer wants to work with us on an application that could be a significant application and they want a six-month head start for their cost of development, I think that's a reasonable discussion. But I think we did some things in the past to try to build up a base load of business that you should not interpret as our forward demeanor and, indeed, we've moved away from that significantly with our current customers.

On the other hand, we have had customers look us in the eyes and tell us if they ever see their name in print, that almost in a punitive fashion, they would go elsewhere. That has nothing to do with the value of the material, at the end of the day they're the customer. So I hear you when you say that that's not normally a deal breaker, we have seen that in some cases. In fact, our largest customer has told us flat out they never want to see their name in print again. Not that it would jeopardize our current business, but we have several other initiatives underway with that huge company that we do not want jeopardized just because we need to be able to speak their name.

There's some obvious things about saying the customer's name and there's some subtle things about saying a customer's name that could impinge upon future business. We don't enter into those things anywhere near easily as we did before because we have a base load now, and we've got a little bit of track history in manufacturing and delivery and sales so we're much more selective on that. But there will be times when customers come to us and say if we ever say their name or we ever talk about their specific application they'll walk. I've been told that personally by two major customers.
Dan Bilicki:
VP Sales & Marketing
This is Dan Bilicki, I'd like to add to that a bit. When we begin any of these processes of trying a joint development, we sign nondisclosure agreements between our respective companies to ensure who owns what IP. In two initiatives that we're currently involved with, in those agreements, it specifically stated that we are not allowed to mention the customer's name. And if we want to do this project, we're going to have to go along with that. It's not a negotiating point, that's their standard boilerplate situation. So we're not about to change that because we're Nanophase. We're going to go after the business and we're going to honor their request.
Todd Cobey: I understand, Dan and Joe, and I appreciate your comments, especially Joe's about how the posture of the company may be changing as you came to credibility in the marketplace and I'm pleased to know that. I want to make sure that management understands how critical this is to shareholders and to any plans the company may have to sell additional equity.
Joseph Cross:
President & CEO
I think we understand, I really do believe we understand.
Todd Cobey: Do you understand that it's really enormously frustrating and critical when we hit these bumps and when we hear something like a BASF, or the United States Navy, it creates an enormous degree of comfort as well as at the time excitement. You can see, for instance from a shareholder's point of view, that whenever you make an announcement of a new customer the stock responds much more so than when you send out a press release about some IP improvement or manufacturing breakthrough.

I know you know that it's important but I've been doing this a long time and it's very important.
Joseph Cross:
President & CEO
Listen, I know it's very important. As somebody in the company who talks to the investment arena and has to make presentations, trust me it's highly awkward standing up and talking about things without being able to name customers. So I'm a little frustrated with it also, but I think we had a certain path early over the last two years to try to get some base business and sales and we had to give some things away maybe. Going forward in the future there's no doubt there's going to be major concern to Dan's point. We have a major opportunity we're working with, probably with a Fortune 50 company, and we think this is a significant, significant piece of business. If we ever mention their name, they'll walk in a heartbeat because they're big enough, they don't care. They'll just walk. And we brought a lot of value to this application, things they've never seen before, but they're real funny about it. So there'll still be customers where we won't be able to talk about but going forward in the future, we're going to take a position as well as we can with customers that we're going to be able to talk about customer applications. But that's not always going to work for us. We're as sensitive to that as you are.
Todd Cobey: Okay. The other issue, which got kind of got lost, although you did address it, was exclusivity. And again when I had an opportunity to be involved in these kind of negotiations, the one thing that keeps a big company from putting it off and putting it off and the guy doesn't want to write a memo to his boss and then the boss moves on and somebody else comes in, is the fear that a competitor will get a hold of the advantage that you've negotiated. I just wondered if you're taking the same position if you're taking a more aggressive stance on exclusivity as well as confidentiality?
Joseph Cross:
President & CEO
Yes, we are. Now that we've got some base business and some business in specific markets, we are much more askance about giving away exclusivity. We will negotiate. In fact, we are working with customers at this moment that have asked for a three to six-month head start. I think that's a fair discussion.
Todd Cobey: Yes. I do, too.
Joseph Cross:
President & CEO
So if they want a three to six months head start on the market, I think that's fair, but we are not entering exclusive agreements with anyone very easily at this point in time. Now on the other hand, frankly, if somebody brought a piece of business that was worth several million dollars to this company and they wanted exclusivity and we thought at this point in our lives that was a reasonable business discussion to advance us to the next level, I'm not sure we'd walk away from that necessarily either. So I think it has to be looked at in context of several different parameters, but in general we don't give exclusivity away lightly.
Todd Cobey: Thank you very much.
Operator: Tom Laird, please state your